EXTENSION OF DEADLINE OF COMMENTS OF DRAFT FDA CIRCULAR ON IMPLEMENTING RULES AND REGULATIONS ON REVISED APPLICATION PROCESS AND REQUIREMENTS FOR POST-APPROVAL CHANGES OF PHARMACEUTICAL PRODUCTS, AND INSTITUTIONALIZATION OF THE PHILIPPINE VARIATION GUIDELINES, AND PHILIPPINE VARIATION GUIDELINES VERSION 1.0

Share this Post!

To provide sufficient time for comments on the subject draft FDA Circular, submission of comments is hereby extended from 5 August 2020 to 14 August 2020.

All comments shall be sent at [email protected].

For your information and compliance.

Attachment:->Philippine Variation Guidelines V.1.0 with fees and charges
Attachment:->Draft Circular for Post Approval Changes and PVG